GBA mutations confer increased risk of cognitive dysfunction among individuals with PD[28], and this may result, pathophysiologically, from a synergistic effect between glucocerebrosidase dysfunction and alpha-synuclein pathology[29]. Here, SNCA is linked to Parkinson disease.